Nuclear hormone receptors in diabetic nephropathy. (Q37737555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Nuclear hormone receptors in diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Xiaoxin X Wang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Tao Jiang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

27 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

342-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Nuclear receptors: genomic and non-genomic effects converge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Protein Kinase A-Dependent Phosphorylation Modulates DNA-Binding Activity of Hepatocyte Nuclear Factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Structural-functional correlations of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Oxidative stress as a major culprit in kidney disease in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The renin-angiotensin system and diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The role of lipid deposition in renal arteriolar sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Effect of lipid reduction on the progression of renal disease: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Do statins have a beneficial effect on the kidney?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The steroid and thyroid hormone receptor superfamily

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The nuclear receptor superfamily: the second decade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

HNF4 alpha and the Ca-channel TRPC1 are novel disease candidate genes in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Nuclear receptors and lipid physiology: opening the X-files

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Discovery of ligands for the nuclear peroxisome proliferator-activated receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Emerging role of PPAR ligands in the management of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator-activated receptors in inflammation control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPAR{alpha} attenuates the proinflammatory response in activated mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator-activated receptor alpha protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexyl)phthalate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

PPARs and the kidney in metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Estrogen signaling: a subtle balance between ER alpha and ER beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Selective estrogen receptor modulators suppress mesangial cell collagen synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Estrogen receptor beta acts as a dominant regulator of estrogen signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Plasma membrane estrogen receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Estrogens and the diabetic kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Gender and the progression of renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Vitamin D and bone health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Renoprotective role of the vitamin D receptor in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Vitamin D receptor as an intestinal bile acid sensor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Acetylation regulates transcription factor activity at multiple levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The role of HNF4A variants in the risk of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Canonical transient receptor potential 1 channel is involved in contractile function of glomerular mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Physiology and pathophysiology of canonical transient receptor potential channels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Identification of a nuclear receptor that is activated by farnesol metabolites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Identification of a nuclear receptor for bile acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Bile acids: natural ligands for an orphan nuclear receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Targeting bile-acid signalling for metabolic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Role of bile acids and bile acid receptors in metabolic regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Transcriptional control of energy homeostasis by the estrogen-related receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2010.56

Effect of gender on the progression of nondiabetic renal disease: a meta-analysis

31 March 2020

1 reference

12 December 2020

Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney

1 reference

12 December 2020

Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans

1 reference

12 December 2020

Intercapillary Lesions in the Glomeruli of the Kidney

1 reference

12 December 2020

Characterization of the human peroxisome proliferator activated receptor delta gene and its expression.

1 reference

12 December 2020

Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney.

1 reference

12 December 2020

Localization of estrogen receptors in interstitial cells of hamster kidney and in estradiol-induced renal tumors as evidence of the mesenchymal origin of this neoplasm

1 reference

12 December 2020

Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2010.56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421884%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference